Emergent Stock Market Sentiment

EBS
 Stock
  

USD 29.72  0.83  2.72%   

Emergent investor sentiment overview provides quick insight into current market opportunities from investing in Emergent Biosolutions. The current market sentiment together Emergent Biosolutions' historical and current headlines can help investors to time the market. Many technical investors use Emergent Biosolutions stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Emergent Biosolutions Hype Analysis, Emergent Biosolutions Correlation and Emergent Biosolutions Performance.
  
Emergent Biosolutions stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Emergent daily returns and investor perception about the current pice of Emergent Biosolutions as well as its diversification or hedging effects on your existing portfolios.

Emergent Historical Sentiment

Although Emergent Biosolutions' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Emergent, such as negative comments on social media and news outlets, may cause fear in the market and push Emergent Biosolutions' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Emergent.
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Emergent Biosolutions' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Emergent Biosolutions.

Emergent Biosolutions Sentiment by Major News Outlets

prnewswire News
reuters
news
Barrons News
benzinga news
Usa forbes News
fool News
zacks News
Macroaxis News
Macroaxis News: globenewswire.com
Macroaxis News: apnews.com
cnbc News
Macroaxis News

Emergent Biosolutions Historical Investor Sentiment

Investor biases related to Emergent Biosolutions' public news can be used to forecast risks associated with investment in Emergent. The trend in average sentiment can be used to explain how an investor holding Emergent can time the market purely based on public headlines and social activities around Emergent Biosolutions. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Emergent Biosolutions' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Emergent Biosolutions' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Emergent Biosolutions' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Emergent Biosolutions.

Emergent Biosolutions Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as Emergent Biosolutions has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether Emergent Biosolutions' prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding Emergent Biosolutions. Our Twitter sentiment analysis of Emergent Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
few days ago at www.nasdaq.com         
Leidos Holdings Seems To Use Debt Quite Sensibly - Nasdaq
nasdaq News
six days ago at www.fool.com         
Why Emergent BioSolutions Stock Is Sinking Today - The Motley Fool
fool News
over a week ago at www.marketscreener.com         
Emergent BioSolutions Reports Financial Results for Second Quarter 2022 - Marketscreener.com
Macroaxis News: marketscreener.com
over a week ago at endpts.com         
Tonix will test its monkeypox vaccine in Kenya next year, and no eyes on accelerated path at FDA - E...
news
over a week ago at www.investorsobserver.com         
Do Traders Think Emergent Biosolutions Inc Can Keep Climbing Thursday - InvestorsObserver
Investors Business Daily at Macroaxis
over a week ago at equalocean.com         
WIM2022 New York Monkeypox Vaccine Helps U.S. MNC Expand into China - EqualOcean
news
over a week ago at seekingalpha.com         
3 Stocks To Play The Potential Monkeypox Pandemic - Seeking Alpha
seekingalpha News
over two weeks ago at www.streetinsider.com         
Hot Penny Stocks To Watch As Monkeypox Gets WHO GHE Designation - StreetInsider.com
Street Insider News
over two weeks ago at www.macroaxis.com         
Acquisition by Dayal Sujata Tyagi of 11852 shares of Emergent Biosolutions subject to Rule 16b-3
Macroaxis News
over two weeks ago at www.gurufocus.com         
Emergent BioSolutions to Relea - GuruFocus.com
Gurufocus Stories at Macroaxis
over a month ago at www.nasdaq.com         
Health Care Sector Update for 07082022 SIGA, ADCT, EBS, XLV, IBB - Nasdaq
nasdaq News
over a month ago at seekingalpha.com         
Emergent BioSolutions, Ridgeback to collaborate for ebola treatment Ebanga - Seeking Alpha
seekingalpha News
over a month ago at finance.yahoo.com         
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors - Yahoo Finance
Yahoo News
over a month ago at www.trefis.com         
Should You Buy Walgreens Stock At 40 - Trefis
news
over a month ago at seekingalpha.com         
U.S. to widen access to monkeypox vaccines - Seeking Alpha
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Emergent Biosolutions that are available to investors today. That information is available publicly through Emergent media outlets and privately through word of mouth or via Emergent internal channels. However, regardless of the origin, that massive amount of Emergent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Emergent Biosolutions news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Emergent Biosolutions relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Emergent Biosolutions' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Emergent Biosolutions alpha.

Emergent Biosolutions Performance against DOW

 Price Growth (%)  
       Timeline  
1
Financial Statements05/16/2022
2
Financial Statements05/18/2022
3
Payment of 1715 shares by Robert Kramer of Emergent Biosolut...05/23/2022
4
Sale by Kathryn Zoon of 1996 shares of Emergent Biosolutions05/25/2022
5
Emergent BioSolutions to Hold Virtual Annual Meeting of Stoc...05/26/2022
6
Financial Statements05/27/2022
7
Acquisition by Kathryn Zoon of 8446 shares of Emergent Bioso...05/31/2022
8
Other06/06/2022
9
Termination of Agreement06/07/2022
10
Whats Happening With Activision Blizzard Stock - Nasdaq06/09/2022
11
Sale by Kathryn Zoon of 1173 shares of Emergent Biosolutions06/13/2022
12
United States Human Vaccines Market Report 2022 A Market Poi...06/27/2022
13
EPS Estimate06/30/2022
14
Emergent BioSolutions Announces Appointment of Sujata Dayal ...07/06/2022
15
Emergent BioSolutions to Relea - GuruFocus.com07/18/2022
16
Acquisition by Dayal Sujata Tyagi of 11852 shares of Emergen...07/22/2022
17
3 Stocks To Play The Potential Monkeypox Pandemic - Seeking ...07/26/2022
18
Tonix will test its monkeypox vaccine in Kenya next year, an...07/29/2022
19
EPS Reported08/01/2022
20
Financial Statements08/02/2022
21
Leidos Holdings Seems To Use Debt Quite Sensibly - Nasdaq08/03/2022
Continue to Emergent Biosolutions Hype Analysis, Emergent Biosolutions Correlation and Emergent Biosolutions Performance. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.022
Market Capitalization
1.6 B
Quarterly Revenue Growth YOY
-0.39
Return On Assets
0.049
Return On Equity
0.0631
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine Emergent Biosolutions value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.